EUVIMEDEUVIMED entdecken
Crossref

Exploring Potential EGFR Inhibitors from Isodon Serra Phytochemicals: Molecular Docking, Dynamics, and ADMET Analysis

Nguyen Xuan Ha, Ngu Thi Tra Giang, Nguyen Thi Phuong Thao, Dau Xuan Duc, Phan Thi Thuy

ChemistrySelect · 2026-11 · 11 (41)

DOI: 10.1002/slct.202505249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 28.10.2026. Verfasst von Nguyen Xuan Ha und 4 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human epidermal growth factor receptor (EGFR), a key oncogenic driver in various cancers, particularly non‐small cell lung cancer (NSCLC), was selected as the molecular target for this investigation. A validated molecular docking protocol was employed using AutoDock Vina, with re‐docking of the co‐crystallized ligand (PDB ID: 1M17) yielding an RMSD of 1.4095 Å, confirming reliability. A total of 155 phytochemicals from Isodon serra were screened based on binding affinity toward EGFR. From this dataset, ten compounds (40, 48, 57, 58, 59, 84, 88, 89, 119, and 146) were identified as top candidates according to their strong binding energies (≤ −9.0 kcal/mol), all exceeding that of the reference inhibitor erlotinib (−7.18 kcal/mol). These top compounds formed key interactions with EGFR catalytic residues, mirroring the binding profile of erlotinib. Compound 88 (11,12‐epoxy‐2,3,13‐trihydroxy‐γ‐lactone oleanan‐28‐oic acid) showed the highest binding affinity (−10.42 kcal/mol). Molecular dynamics (MD) simulations over 100 ns confirmed the structural stability of these ligand–EGFR complexes. RMSD, RMSF, and radius of gyration (Rg) analyses revealed that complexes particularly stabilized the EGFR protein, maintaining compact conformations and reduced residue fluctuations compared to apo and reference systems. ADMET profiling indicated generally favorable pharmacokinetic properties, although limitations related to solubility and potential toxicity were identified for several studied compounds. DFT calculations supported the electronic stability and reactivity of the top ligands, with compound 88 displaying a favorable electronic profile. Collectively, this integrated in silico approach highlights Isodon serra phytochemicals, especially compound 88, as promising natural EGFR inhibitors. These findings provide a rational basis for subsequent experimental validation (in vitro and in vivo) and the development of novel anticancer agents targeting EGFR.

Zitieren

APA

Ha, N. X., Giang, N. T. T., Thao, N. T. P., Duc, D. X., & Thuy, P. T. (2026). Exploring Potential EGFR Inhibitors from Isodon Serra Phytochemicals: Molecular Docking, Dynamics, and ADMET Analysis. ChemistrySelect, 11(41). https://doi.org/10.1002/slct.202505249

Vancouver

Ha NX, Giang NTT, Thao NTP, Duc DX, Thuy PT. Exploring Potential EGFR Inhibitors from Isodon Serra Phytochemicals: Molecular Docking, Dynamics, and ADMET Analysis. ChemistrySelect. 2026;11(41). doi:10.1002/slct.202505249

BibTeX
@article{Ha2026,
  author = {Ha, Nguyen Xuan and Giang, Ngu Thi Tra and Thao, Nguyen Thi Phuong and Duc, Dau Xuan and Thuy, Phan Thi},
  title = {Exploring Potential EGFR Inhibitors from Isodon Serra Phytochemicals: Molecular Docking, Dynamics, and ADMET Analysis},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {41},
  doi = {10.1002/slct.202505249}
}
Kostenlos starten →